BRAIN Biotech AG
XETRA:BNN

Watchlist Manager

BRAIN Biotech AG

XETRA:BNN

Watchlist

Dividends

Price: 3.44 EUR -0.86%

Market Cap: 75.2m EUR

Have any thoughts about
BRAIN Biotech AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 3.44 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BNN Alert

BRAIN Biotech AG

3.44

-0.03 (-0.86%)

52 Week Range	1.445 4.3
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

BRAIN Biotech AG

What unique competitive advantages
does BRAIN Biotech AG hold over its rivals?

What risks and challenges
does BRAIN Biotech AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of BRAIN Biotech AG.

What unique competitive advantages
does BRAIN Biotech AG hold over its rivals?

What risks and challenges
does BRAIN Biotech AG face in the near future?

Has there been any significant insider trading activity
in BRAIN Biotech AG recently?

Summarize the latest earnings call
of BRAIN Biotech AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BRAIN Biotech AG.

Provide P/S
for BRAIN Biotech AG.

Provide P/E
for BRAIN Biotech AG.

Provide P/OCF
for BRAIN Biotech AG.

Provide P/FCFE
for BRAIN Biotech AG.

Provide P/B
for BRAIN Biotech AG.

Provide EV/S
for BRAIN Biotech AG.

Provide EV/GP
for BRAIN Biotech AG.

Provide EV/EBITDA
for BRAIN Biotech AG.

Provide EV/EBIT
for BRAIN Biotech AG.

Provide EV/OCF
for BRAIN Biotech AG.

Provide EV/FCFF
for BRAIN Biotech AG.

Provide EV/IC
for BRAIN Biotech AG.

Show me price targets
for BRAIN Biotech AG made by professional analysts.

What are the Revenue projections
for BRAIN Biotech AG?

How accurate were the past Revenue estimates
for BRAIN Biotech AG?

What are the Net Income projections
for BRAIN Biotech AG?

How accurate were the past Net Income estimates
for BRAIN Biotech AG?

What are the EPS projections
for BRAIN Biotech AG?

How accurate were the past EPS estimates
for BRAIN Biotech AG?

What are the EBIT projections
for BRAIN Biotech AG?

How accurate were the past EBIT estimates
for BRAIN Biotech AG?

Compare the revenue forecasts
for BRAIN Biotech AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BRAIN Biotech AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BRAIN Biotech AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of BRAIN Biotech AG compared to its peers.

Compare the P/E ratios
of BRAIN Biotech AG against its peers.

Discuss the investment returns and shareholder value creation
comparing BRAIN Biotech AG with its peers.

Analyze the financial leverage
of BRAIN Biotech AG compared to its main competitors.

Show all profitability ratios
for BRAIN Biotech AG.

Provide ROE
for BRAIN Biotech AG.

Provide ROA
for BRAIN Biotech AG.

Provide ROIC
for BRAIN Biotech AG.

Provide ROCE
for BRAIN Biotech AG.

Provide Gross Margin
for BRAIN Biotech AG.

Provide Operating Margin
for BRAIN Biotech AG.

Provide Net Margin
for BRAIN Biotech AG.

Provide FCF Margin
for BRAIN Biotech AG.

Show all solvency ratios
for BRAIN Biotech AG.

Provide D/E Ratio
for BRAIN Biotech AG.

Provide D/A Ratio
for BRAIN Biotech AG.

Provide Interest Coverage Ratio
for BRAIN Biotech AG.

Provide Altman Z-Score Ratio
for BRAIN Biotech AG.

Provide Quick Ratio
for BRAIN Biotech AG.

Provide Current Ratio
for BRAIN Biotech AG.

Provide Cash Ratio
for BRAIN Biotech AG.

What is the historical Revenue growth
over the last 5 years for BRAIN Biotech AG?

What is the historical Net Income growth
over the last 5 years for BRAIN Biotech AG?

What is the current Free Cash Flow
of BRAIN Biotech AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for BRAIN Biotech AG.

BNN

Balance Sheet

Intangible Assets

BRAIN Biotech AG
Intangible Assets

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

BRAIN Biotech AG
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Intangible Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
BRAIN Biotech AG XETRA:BNN	Intangible Assets €14.6m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Wacker Chemie AG XETRA:WCH	Intangible Assets €297.1m	CAGR 3-Years 88%	CAGR 5-Years 55%	CAGR 10-Years 25%
Evonik Industries AG XETRA:EVK	Intangible Assets €876m	CAGR 3-Years -47%	CAGR 5-Years -32%	CAGR 10-Years -12%
Covestro AG XETRA:1COV	Intangible Assets €486m	CAGR 3-Years -12%	CAGR 5-Years 35%	CAGR 10-Years N/A
AlzChem Group AG XETRA:ACT	Intangible Assets €3.7m	CAGR 3-Years 27%	CAGR 5-Years 32%	CAGR 10-Years N/A
Symrise AG XETRA:SY1	Intangible Assets €2.7B	CAGR 3-Years 8%	CAGR 5-Years 8%	CAGR 10-Years N/A

No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap

75.2m EUR

Industry

Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

Open BNN Analysis

BNN Intrinsic Value

5.16 EUR

Undervaluation 33%

Intrinsic Value

Price

What is Intrinsic Value?

What is BRAIN Biotech AG's Intangible Assets?

Intangible Assets
14.6m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Intangible Assets amounts to 14.6m EUR.

	Franklin Covey Co NYSE:FC	36.87 USD 1.57%
	Mohawk Industries Inc NYSE:MHK	120.19 USD 0.54%
	Ardmore Shipping Corp NYSE:ASC	12.12 USD 2.02%
	ASGN Inc NYSE:ASGN	84.15 USD 0.71%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.95%

	Johnson & Johnson NYSE:JNJ	145.85 USD 0.4%
	Bank of America Corp NYSE:BAC	44.38 USD 1.12%
	Mastercard Inc NYSE:MA	535.71 USD 1.28%
	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Abbvie Inc NYSE:ABBV	180 USD 0.9%
	Home Depot Inc NYSE:HD	396.14 USD 0.94%

	Arista Networks Inc NYSE:ANET	114.65 USD 1.38%
	Visa Inc NYSE:V	320.65 USD 1.08%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	650.53 USD 0.39%
	Manhattan Associates Inc NASDAQ:MANH	282.27 USD 1.24%
	Pinduoduo Inc NASDAQ:PDD	99.72 USD -0.86%

	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Accenture PLC NYSE:ACN	361.63 USD 0.8%
	ServiceNow Inc NYSE:NOW	1 105.56 USD 1.59%
	EOG Resources Inc NYSE:EOG	120.83 USD 0.82%
	Copart Inc NASDAQ:CPRT	59.11 USD 1.29%
	Applied Materials Inc NASDAQ:AMAT	168.37 USD 0.54%

BRAIN Biotech AG
XETRA:BNN

BRAIN Biotech AG
Intangible Assets

BRAIN Biotech AG
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

BRAIN Biotech AG
Glance View

See Also

What is BRAIN Biotech AG's Intangible Assets?

Intangible Assets
14.6m EUR

Company

Help

Tools

Stocks

BRAIN Biotech AG XETRA:BNN

BRAIN Biotech AG Intangible Assets

BRAIN Biotech AG Intangible Assets Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

BRAIN Biotech AG Glance View

See Also

What is BRAIN Biotech AG's Intangible Assets? Intangible Assets 14.6m EUR

Company

Help

Tools

Stocks

BRAIN Biotech AG
XETRA:BNN

BRAIN Biotech AG
Intangible Assets

BRAIN Biotech AG
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

BRAIN Biotech AG
Glance View

What is BRAIN Biotech AG's Intangible Assets?

Intangible Assets
14.6m EUR